Reinforcing and subjective effects of the volatile anesthetic, sevoflurane

Drug and Alcohol Dependence

Volumn 76, Issue 2, 2004, Pages 191-201

  Walker, Diana J ^a   Beckman, Nancy J ^a   Zacny, James P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Choice; Human; Inhalants; Reinforcing effects; Sevoflurane; Volatile substance abuse

Indexed keywords

INHALATION ANESTHETIC AGENT; SEVOFLURANE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REINFORCEMENT;

ADMINISTRATION, INHALATION; ADULT; AFFECT; ANESTHETICS, INHALATION; AROUSAL; CHOICE BEHAVIOR; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EUPHORIA; FEMALE; HUMANS; MALE; METHYL ETHERS; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE-RELATED DISORDERS;

EID: 5644236807     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2004.05.002     Document Type: Article

References (61)

1. Atkinson R.M., Morozumi P., Green J.D., Kramer J.C. Nitrous oxide intoxication: subjective effects in healthy young men. J. Psychedelic Drugs. 9:1977;317-328
2. Balster R.L. Neural basis of inhalant abuse. Drug Alcohol Depend. 51:1998;207-214
3. Beckstead M.J., Phelan R., Mihic S.J. Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function. J. Biol. Chem. 276:2001;24959-24964
4. A receptor function is enhanced by inhaled drugs of abuse. Mol. Pharmacol. 57:2000;1199-1205
5. Block R.I., Ghoneim M.M., Kumar V., Pathak D. Psychedelic effects of a subanesthetic concentration of nitrous oxide. Anesth. Prog. 37:1990;271-276
6. Bowdle T.A., Radant A.D., Cowley D.S., Kharasch E.D., Strassman R.J., Roy-Byrne P.P. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology. 88:1998;82-88
7. Bowen S.E., Balster R.L. Desflurane, enflurane, isoflurane and ether produce ethanol-like discriminative stimulus effects in mice. Pharmacol. Biochem. Behav. 57:1997;191-198
8. Bowen S.E., Balster R.L. A direct comparison of inhalant effects on locomotor activity and schedule-controlled behavior in mice. Exp. Clin. Psychopharmacol. 6:1998;235-247
9. Bowen S.E., Wiley J.L., Balster R.L. The effects of abused inhalants on mouse behavior in an elevated plus-maze. Eur. J. Pharmacol. 312:1996a;131-136
10. Bowen S.E., Wiley J.L., Evans E.B., Tokarz M.E., Balster R.L. Functional observational battery comparing effects of ethanol, 1,1,1-trichloroethane, ether, and flurothyl. Neurotoxicol. Teratol. 18:1996b;577-585
11. Bowen S.E., Wiley J.L., Jones H.E., Balster R.L. Phencyclidine- and diazepam-like discriminative stimulus effects of inhalants in mice. Exp. Clin. Psychopharmacol. 7:1999;28-37
12. Branch, M.N., 1991. Behavioral pharmacology. In: Iversen, I.H., Lattal, K.A. (Eds.), Experimental Analysis of Behavior. Part 2. Elsevier, Amsterdam, pp. 21-77.
13. Brouette T., Anton R. Clinical review of inhalants. Am. J. Addict. 10:2001;79-94
14. Campagna J.A., Miller K.W., Forman S.A. Mechanisms of actions of inhaled anesthetics. N. Engl. J. Med. 348:2003;2110-2124
15. Carlton, P.L., 1983. A Primer of Behavioral Pharmacology. Freeman and Company, New York.
16. Chait L.D. Factors influencing the reinforcing and subjective effects of d-amphetamine in humans. Behav. Pharmacol. 4:1993;191-199
17. Chutuape M.A., de Wit H. Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug Alcohol Depend. 34:1994;243-251
18. Cohen S. The hallucinogens and the inhalants. Psychiatr. Clin. N. Am. 7:1984;681-688
19. Comer S.D., Haney M., Foltin R.W., Fischman M.W. Amphetamine self-administration by humans: modulation by contingencies associated with task performance. Psychopharmacology. 127:1996;39-46
20. de Wit H. Individual differences in acute effects of drugs in humans: their relevance to risk for abuse. NIDA Res. Monogr. 169:1998;176-187
21. de Wit H., Pierri J., Johanson C.E. Assessing individual differences in ethanol preference using a cumulative dosing procedure. Psychopharmacology. 98:1989a;113-119
22. de Wit H., Pierri J., Johanson C.E. Assessing pentobarbital preference in normal volunteers using a cumulative dosing procedure. Psychopharmacology. 99:1989b;416-421
23. de Wit H., Pierri J., Johanson C.E. Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers. Pharmacol. Biochem. Behav. 33:1989c;205-213
24. de Wit H., Uhlenhuth E.H., Hedeker D., McCracken S.G., Johanson C.E. Lack of preference for diazepam in anxious volunteers. Arch. Gen. Psychiatr. 43:1986a;533-541
25. de Wit H., Uhlenhuth E.H., Johanson C.E. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend. 16:1986b;341-360
26. de Wit H., Uhlenhuth E.H., Pierri J., Johanson C.E. Individual differences in behavioral and subjective responses to alcohol. Alcohol. Clin. Exp. Res. 11:1987;52-59
27. Dillman J.M. Substance abuse in the perioperative setting. AORN J. 62:1995;111-112
28. Dohrn C.S., Lichtor J.L., Coalson D.W., Flemming D., Zacny J.P. Reinforcing effects of extended inhalation of a low nitrous oxide concentration in humans. Pharmacol. Biochem. Behav. 46:1993a;927-932
29. Dohrn C.S., Lichtor J.L., Coalson D.W., Uitvlugt A., de Wit H., Zacny J.P. Reinforcing effects of extended inhalation of nitrous oxide in humans. Drug Alcohol Depend. 31:1993b;265-280
30. Dohrn C.S., Lichtor J.L., Finn R.S., Uitvlugt A., Coalson D.W., Rupani G., Zacny J.P. Subjective and psychomotor effects of nitrous oxide in healthy volunteers. Behav. Pharmacol. 3:1992;19-30
31. Doi M., Ikeda K. Airway irritation produced by volatile anaesthetics during brief inhalation: comparison of halothane, enflurane, isoflurane and sevoflurane. Can. J. Anaesth. 40:1993;122-126
32. Ebert, T.J., Schmid III, P.G., 2001. Inhalation anesthesia. In: Barash, P.G., Cullen, B.F., Stoelting, R.K. (Eds.), Clinical Anesthesia, third ed. Lippincott Williams & Wilkins, Philadelphia, pp. 377-417.
33. Evans S.E., Balster R.L. CNS Depressant effects of volatile organic solvents. Neurosci. Biobehav. Rev. 15:1991;233-241
34. Galinkin J.L., Janiszewski D., Young C.J., Klafta J.M., Klock P.A., Coalson D.W., Apfelbaum J.L., Zacny J.P. Subjective, psychomotor, cognitive and analgesic effects of subanesthetic concentrations of sevoflurane and nitrous oxide. Anesthesiology. 87:1997;1082-1088
35. Griffiths R.R., Bigelow G., Liebson I. Human drug self-administration: double-blind comparison of pentobarbital, diazepam, chlorpromazine, and placebo. J. Pharmacol. Exp. Ther. 210:1979;301-310
36. Griffiths R.R., Woodson P.P. Reinforcing effects of caffeine in humans. J. Pharmacol. Exp. Ther. 246:1988;21-29
37. Henningfield J.E., Cohen C., Heishman S.J. Drug self-administration methods in abuse liability evaluation. Br. J. Addict. 86:1991;1571-1577
38. Henningfield J.E., Miyasato K., Jasinski D.R. Cigarette smokers self-administer intravenous nicotine. Pharmacol. Biochem. Behav. 19:1983;887-890
39. Janiszewski D.J., Galinkin J.L., Klock P.A., Coalson D.W., Pardo H., Zacny J.P. The effects of subanesthetic concentrations of sevoflurane and nitrous oxide, alone and in combination, on analgesia, mood, and psychomotor performance in healthy volunteers. Anesth. Analg. 88:1999;1149-1154
40. Meisch R.A. Factors controlling drug-reinforced behavior. Pharmacol. Biochem. Behav. 27:1987;367-371
41. Mintzer M.Z., Griffiths R.R. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability. Drug Alcohol Depend. 53:1998;49-66
42. Rees D.C., Coggeshall E., Balster R.L. Inhaled toluene produces pentobarbital-like discriminative stimulus effects in mice. Life Sci. 37:1985;1319-1325
43. Rees D.C., Knisely J.S., Breen T.J., Balster R.L. Pentobarbital-like discriminative stimulus properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice. J. Pharmacol. Exp. Ther. 241:1987a;507-515
44. Rees D.C., Knisely J.S., Breen T.J., Balster R.L. Toluene, halothane, 1,1,1-trichloroethane and oxazepam produce ethanol-like discriminative stimulus effects in mice. J. Pharmacol. Exp. Ther. 243:1987b;931-937
45. Rose J.E., Corrigall W.A. Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology. 130:1997;28-40
46. Rush C.R., Frey J.M., Griffiths R.R. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential. Psychopharmacology. 145:1999;39-51
47. Sharp, C.W., Rosenberg, N.L., 1997. Inhalants. In: Lowinson, J.H., Ruiz, P., Millman, R.B., Langrod, J.G. (Eds.), Substance Abuse, a Comprehensive Textbook, third ed. Williams & Wilkins, Baltimore, pp. 246-264.
48. Silverman K., Kirby K.C., Griffiths R.R. Modulation of drug reinforcement by behavioral requirements following drug ingestion. Psychopharmacology. 114:1994;243-247
49. Smith K.M., Larive L.L., Romanelli F. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and γ-hydroxybutyrate. Am. J. Health Syst. Pharm. 59:2002;1067-1076
50. Spiga, R., Roache J.D., 1997. Human drug self-administration: a review and methodological critique. In: Johnson, B.A., Roache, J.D. (Eds.), Drug Addiction and its Treatment: Nexus of Neuroscience and Behavior. Lippincott-Raven Publishers, Philadelphia, pp. 39-71.
51. US Department of Health and Human Services, 2000. Inhalant Abuse. National Institute on Drug Abuse Research Report Series, NIH Publication Number 00-3818.
52. US Department of Health and Human Services, 2002. Rising to the challenges of inhalant abuse. NIDA Notes 17, 3-4.
53. Walker D.J., Zacny J.P. Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers. Drug Alcohol Depend. 64:2001;85-96
54. Walker D.J., Zacny J.P. Analysis of the reinforcing and subjective effects of different doses of nitrous oxide using a free-choice procedure. Drug Alcohol Depend. 66:2002;93-103
55. Walker D.J., Zacny J.P. Bitonic dose-response functions for reinforcing and self-reported effects of nitrous oxide in humans. Pharmacol. Biochem. Behav. 74:2003;851-857
56. Wechsler, D., 1958. The Measurement and Appraisal of Adult Intelligence. Williams and Wilkins, Baltimore.
57. Yamashita M., Matsuki A., Oyama T. Illicit use of modern volatile anesthetics. Can. Anaesth. Soc. J. 31:1984;76-79
58. Yang N.C., Hwang K.L., Hung D.Z., Wuhh H.H., Ho W.M. Reliable gas chromatographic-mass spectrometric method combined with a headspace autosampler for isoflurane determination in blood. J. Chromatogr. 742:2000;277-282
59. Zacny J.P., Janiszewski D., Sadeghi P., Black M.L. Reinforcing, subjective, and psychomotor effects of sevoflurane and nitrous oxide in moderate-drinking healthy volunteers. Addiction. 94:1999;1817-1828
60. Zacny J.P., Lichtor J.L., Coalson D.W., Alessi R., Goldsher G., Young C.J., Apfelbaum J.L., Conley K.M. Examining the subjective, psychomotor and reinforcing effects of nitrous oxide in healthy volunteers: a dose-response analysis. Behav. Pharmacol. 7:1996;194-199
61. Zacny J.P., Sparacino G., Hoffmann P.M., Martin R., Lichtor J.L. The subjective, behavioral and cognitive effects of subanesthetic concentrations of isoflurane and nitrous oxide in healthy volunteers. Psychopharmacology. 114:1994;409-416